COUR Pharmaceuticals Development Co. and Ironwood Pharmaceuticals welcome you to the joint PBC Clinical Symposium, “Reprogramming the Immune System with CNP-104: Working Hand in Hand to Induce Immune Tolerance in PBC Patients"
*This content will be recorded and available for on-demand viewing